Advertisement
UCB Announces Commercial Availability Of Zilbrysq In U.S. To Treat Generalized Myasthenia Gravis
(RTTNews) - Biopharmaceutical company UCB announced Wednesday that ZILBRYSQ (zilucoplan) is now available in the U.S. for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
ZILBRYSQ was approved by the U.S. Food and Drug Administration (FDA) on October 17, 2023.
ZILBRYSQ is available by prescription as a ready-to-use pre-filled syringe that is a once-daily administration. Healthcare providers who prescribe ZILBRYSQ must enroll in the ZILBRYSQ REMS because of the risk of serious meningococcal infections.
Myasthenia gravis is a rare, chronic, autoimmune neuromuscular disease, which is characterized by muscle weakness that worsens after periods of activity and improves after periods of rest.
read more
UCB Announces U.S. Availability Of BIMZELX To Treat Adults With Moderate-to-Severe Plaque Psoriasis
Biopharmaceutical company UCB (UCB) announced Tuesday the commercial availability of BIMZELX in the United States for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
RTTNews
|
674 дней спустя
South Africa Holds Rate Steady At 7% After Easing For A Year
The South African Reserve Bank left its key interest rate unchanged at 7 percent as policymakers decided to adopt a wait-and-watch stance following a year-long easing and they also assessed that inflation is set to rise in the coming months due to higher prices for electricity, food and services, while economic growth is set to strengthen.
RTTNews
|
1ч 51мин назад
Swiss Market Ends On Firm Note
After a positive start, the Switzerland market suffered a mild setback and slipped slightly below the flat line Thursday morning, but recovered swiftly and stayed firm thereafter to finally end the day's session modestly higher.
RTTNews
|
3ч 10мин назад
Major European Markets Close On Firm Note
The major European markets closed higher on Thursday, with investors reacting positively to the Federal Reserve's rate cut and its comments suggesting more easing this year. The Bank of England left interest rates unchanged, as widely expected.
RTTNews
|
3ч 38мин назад
Technology Stocks Shine; TSX Up Nearly 0.5%
After opening marginally up, the Canadian market moved ahead Thursday morning, and remains firmly in positive territory a little before noon. Technology stocks have recovered from previous session's losses, contributing significantly to market's upmove.
RTTNews
|
5ч 28мин назад
U.S. Leading Economic Index Falls Much More Than Expected In August
Leading U.S. economic indicators fell by much more than expected in the month of August, according to a report released by the Conference Board on Thursday. The Conference Board said its leading economic index slid by 0.5 percent in August after inching up by a revised 0.1 percent in July. Economists had expected the leading economic index to edge down by 0.1 percent.
RTTNews
|
6ч 34мин назад
Philly Fed Index Surges To Eight-Month High In September
A report released by the Federal Reserve Bank of Philadelphia on Thursday said regional manufacturing activity expanded overall in the month of September. The Philly Fed said its diffusion index for current general activity spiked to a positive 23.2 in September from a negative 0.3 in August, with a positive reading indicating growth. Economists had expected the index to rise to a positive 2.3.
RTTNews
|
7ч 16мин назад
Bank Of England Holds Key Rate; Slows Quantitative Tightening
The Bank of England left its interest rate unchanged and softened its pace of quantitative tightening on Thursday, as policymakers were wary about risks to inflation in the U.K. The BoE Monetary Policy Committee, led by Governor Andrew Bailey, voted 7-2 to maintain the bank rate at 4.00 percent.
RTTNews
|
7ч 16мин назад
